Cgta Research Group
CGTA Research Group, located in St. Paul, MN, is dedicated to accelerating the translation of gene therapies for rare Central Nervous System diseases into clinical trials and practical use. Their primary focus is on developing a gene therapy for Huntington's disease, utilizing advanced techniques to address the complexities of this challenging condition.
The group has made significant progress in their research, presenting interim findings at various scientific conferences and continuously monitoring the effects of their treatments in animal studies. They aim to ensure safety and efficacy through meticulous investigation and analysis, all while remaining committed to advancing therapeutic options for patients suffering from Huntington's disease and similar disorders.
Generated from the website
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.